Regen BioPharma Inc Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2013 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Regen BioPharma Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2013 to Q2 2024.
  • Regen BioPharma Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 4.21M shares, a 24.6% increase year-over-year.
  • Regen BioPharma Inc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 3.54M shares, a 12.8% increase from 2022.
  • Regen BioPharma Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 3.14M shares, a 99.9% decline from 2021.
  • Regen BioPharma Inc annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 3.01B shares, a 114% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 4.21M +832K +24.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 3.94M +2.28M +138% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-24
Q4 2023 3.6M +235K +7.01% Oct 1, 2023 Dec 31, 2023 10-Q 2024-01-19
Q3 2023 3.54M +401K +12.8% Jul 1, 2023 Sep 30, 2023 10-K 2023-11-20
Q2 2023 3.38M +192K +6.03% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 1.66M -1.39M -45.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-24
Q4 2022 3.36M -4.5B -99.9% Oct 1, 2022 Dec 31, 2022 10-Q 2024-01-19
Q3 2022 3.14M -3.01B -99.9% Jul 1, 2022 Sep 30, 2022 10-K 2023-11-20
Q2 2022 3.19M -3.57B -99.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-25
Q1 2022 3.04M -2.45B -99.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-18
Q4 2021 4.51B +2.74B +155% Oct 1, 2021 Dec 31, 2021 10-Q 2023-01-19
Q3 2021 3.01B +1.6B +114% Jul 1, 2021 Sep 30, 2021 10-K 2022-11-15
Q2 2021 3.57B +1.97B +123% Apr 1, 2021 Jun 30, 2021 10-Q/A 2021-12-22
Q1 2021 2.46B +882M +56% Jan 1, 2021 Mar 31, 2021 10-Q 2021-08-18
Q4 2020 1.77B +933M +112% Oct 1, 2020 Dec 31, 2020 10-Q 2022-01-20
Q3 2020 1.41B -661M -31.9% Jul 1, 2020 Sep 30, 2020 10-K 2021-12-22
Q2 2020 1.61B +1.52B +1769% Apr 1, 2020 Jun 30, 2020 10-Q/A 2021-12-22
Q1 2020 1.58B +1.28B +433% Jan 1, 2020 Mar 31, 2020 10-Q 2021-08-18
Q4 2019 836M +624M +295% Oct 1, 2019 Dec 31, 2019 10-Q 2021-08-13
Q3 2019 2.07B +1.92B +1262% Jul 1, 2019 Sep 30, 2019 10-K 2021-08-04
Q2 2019 85.9M -67.6M -44.1% Apr 1, 2019 Jun 30, 2019 10-Q 2021-08-05
Q1 2019 296M +150M +103% Jan 1, 2019 Mar 31, 2019 10-Q 2021-08-05
Q4 2018 212M +68.8M +48.1% Oct 1, 2018 Dec 31, 2018 10-Q 2021-08-05
Q3 2018 152M +10.7M +7.54% Jul 1, 2018 Sep 30, 2018 10-K 2021-06-21
Q2 2018 154M +15.4M +11.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-10-24
Q1 2018 145M +3.57M +2.52% Jan 1, 2018 Mar 31, 2018 10-Q 2019-08-29
Q4 2017 143M -519K -0.36% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-12
Q3 2017 141M +13.6M +10.6% Jul 1, 2017 Sep 30, 2017 10-K 2018-12-27
Q2 2017 138M +9.35M +7.26% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 142M +16.9M +13.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 144M +25.4M +21.5% Oct 1, 2016 Dec 31, 2016 10-Q 2017-01-27
Q3 2016 128M +39.7M +45% Jul 1, 2016 Sep 30, 2016 10-K 2016-12-21
Q2 2016 129M +18.1M +16.4% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-01
Q1 2016 125M +52.9M +73.5% Jan 1, 2016 Mar 31, 2016 10-Q 2016-04-29
Q4 2015 118M +66.2M +127% Oct 1, 2015 Dec 31, 2015 10-Q 2017-01-27
Q3 2015 88.2M +36.5M +70.5% Jul 1, 2015 Sep 30, 2015 10-K 2016-12-21
Q2 2015 111M +58.7M +113% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-01
Q1 2015 72M +20.1M +38.7% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-29
Q4 2014 52M +236K +0.46% Oct 1, 2014 Dec 31, 2014 10-Q/A 2017-04-28
Q3 2014 51.7M Jul 1, 2014 Sep 30, 2014 10-K/A 2017-04-28
Q2 2014 51.9M +27.7M +115% Apr 1, 2014 Jun 30, 2014 10-Q/A 2017-04-28
Q1 2014 51.9M +51.9M Jan 1, 2014 Mar 31, 2014 10-Q/A 2017-04-28
Q4 2013 51.8M Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-04
Q2 2013 24.2M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 10K* Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.